Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Futures tied to Canada’s main equity benchmark were muted as markets reacted to fresh statements from U.S. President Donald Trump and escalating military actions across the Middle East. Traders parsed comments suggesting the conflict could broaden, threats to the Strait of Hormuz and evolving developments that sent oil and bond markets swinging bef…
Toronto police responded early on March 10 to reports of gunfire at the U.S. consulate and found evidence consistent with a discharged firearm, with no injuries reported. U.S. diplomatic representatives did not immediately respond to inquiries. The Toronto incident comes as investigators pursue leads in a separate explosion at the U.S. embassy in O…
Goldman Sachs data shows short positioning across U.S. macro products - including index and ETF exposures - has climbed to its highest level since September 2022. The bank warns that crowded bearish bets, elevated hedge fund leverage and dealer short gamma create conditions that could produce abrupt market moves, particularly to the upside if negat…
Altria offers an attractive entry point for income-oriented traders who want upside from smoke-free adoption and near-term dividend capture. The company trades at a reasonable P/E and generates strong free cash flow versus dividend obligations, while technicals and short interest suggest limited downside momentum. This trade targets a measured long…
Bank of America has resumed coverage of Qualcomm with an Underperform rating and a $145 price objective, citing subdued revenue and earnings growth through fiscal 2028, the likely loss of Apple modem revenue, and rising in-house semiconductor efforts from major customers. While Qualcomm's moves into automotive, IoT and AI infrastructure offer diver…
European airline stocks advanced after a sharp drop in crude prices following comments by U.S. President Donald Trump that the Iran war would end soon. Data from Morgan Stanley showed notable increases in fares on several long-haul routes and stronger yields in April, while JPMorgan highlighted mixed but potentially offsetting effects for carriers …
TD Cowen cut its recommendation on Novo Nordisk to Hold and lowered the price target to $42, warning that the company faces significant headwinds as semaglutide approaches loss of exclusivity. The bank pointed to disappointing trial results, slower-than-expected Ozempic prescriptions and lingering questions about long-term demand for oral GLP-1 com…
Human Rights Watch reported that white phosphorus munitions were used by Israeli forces over residential areas of the southern Lebanese town of Yohmor on March 3, creating hazards for civilians. The rights group said it verified imagery and civil defence footage indicating use of the incendiary material, while Israeli authorities said they were una…
Amplify Energy (AMPY) is a small, asset-light E&P with recent asset sales, a clean credit line and modest leverage. In an Iran-driven spike in oil prices, AMPY's valuation, cash position and leverage profile could drive a fast, outsized move. This is a high-risk, high-reward swing trade sized for mid-term upside while protecting capital with a stri…
C4 Therapeutics (CCCC) has reignited interest after Phase 1 data and a program push for cemsidomide, an IKZF1/3 degrader for multiple myeloma. The stock is trading near its 52-week high as momentum accelerates; we outline a long trade that captures upside into clinical readouts while protecting capital if the story stalls.
Compass (COMP) just crossed an important inflection point: scale from the Anywhere merger plus positive free cash flow and sub-1x price-to-sales create an asymmetric risk/reward. I recommend a long entry at $9.06 with a $7.50 stop and a $13.00 target over the next 180 trading days, driven by $225M+ annual synergies, a $203M free cash flow base, and…
Salesforce recently sold off with the broader 'SaaSpocalypse' rout, but its fundamentals - record revenue cadence, $14.4B free cash flow, and a manageable balance sheet - argue for a tactical long. This idea outlines a mid-term (45 trading days) trade: entry at $198.79, target $250.00, stop $175.00. Reward-to-risk is attractive and several near-ter…
MasterCraft (MCFT) is trading below key moving averages and into oversold RSI territory after a pullback from its February highs. Fundamentals show profitable operations, solid free cash flow and a conservative balance sheet; the Marine Products acquisition and fresh product launches provide clear catalysts. This trade idea outlines an actionable l…
The Vatican has accepted the resignation of Bishop Emanuel Hana Shaleta, who led the Chaldean Catholic community in San Diego since 2017 and was arrested on suspicion of stealing $250,000 from his congregation. Local prosecutors say the alleged conduct occurred in 2024; the bishop pleaded not guilty to 16 counts of embezzlement and money laundering…
Monika U. Ehrman, a director at Matador Resources Co (NYSE: MTDR), purchased 267 shares on March 6, 2026, for $56.29 each, a transaction worth $15,029. The purchase brings her direct holdings to 41,463 shares. Matador's stock is trading near a 52-week high after a strong year-to-date gain, while the company has completed a significant tender of its…
Baird mapped out three potential outcomes for global athletic and retail brand equities as crude oil holds above $100 per barrel on Day 10 of Operation Epic Fury, a U.S.-Iran conflict that began on February 28. The firm weighed a rapid de-escalation, a prolonged high-price environment, and a worst-case recession scenario, and identified a group of …
Bank of America’s quantitative models signal further U.S. dollar gains as option-market positioning, technical trend indicators and cross-asset regime analysis point to continued demand for the dollar as a relative safe haven. The bank also highlights the Canadian dollar as a notable opportunity while noting uneven investor conviction across time z…
Macquarie analysts say ongoing conflict in Iran and associated maritime disruptions are creating immediate freight and fuel cost pressures that could weigh on Australian household retailers, particularly furniture sellers. The firm quantifies an immediate negative impact exceeding 2% on fiscal year 2027 net profit after tax if current conditions pe…
Citi Research upgraded Centrica Plc from "neutral" to "buy" and increased its 12-month price target to £2.18 from £2, citing heightened geopolitical risks and rising gas prices as drivers that make government support for strategic energy infrastructure - notably the Rough gas storage facility - more likely. Citi's valuation incorporates potential n…
Barclays analysts say the waste management sector is positioned to absorb rising fuel costs driven by the Iran war through existing surcharge programs and selective pricing levers. Coverage has outperformed the S&P 500 since the conflict began, and firm-level mechanisms differ in speed and scope of pass-through, producing a mixed but generally supp…
Growing use of GLP-1 weight-loss drugs in the U.S. is altering eating habits and taste perception, increasing demand for bold condiments and seasonings. Recent acquisitions of Bachan's and Tapatio illustrate heightened buyer appetite and above-average valuations in the specialty sauce category as buyers position for a long-term shift toward lean pr…
Cerus Corporation's Chief Medical Officer, Richard J. Benjamin, disposed of 125,894 shares of common stock between March 5 and March 9, 2026, totaling approximately $250,931. The trades included pre-arranged 10b5-1 plan sales and a transaction to meet tax and brokerage obligations tied to vested restricted stock units. The activity coincides with r…
CRISPR Therapeutics AG said it plans a private offering of $350 million in convertible senior notes due 2031, and its stock slid 6.75% on Tuesday. The company will offer the notes to qualified institutional buyers under Rule 144A and may allow initial purchasers to buy up to an additional $52.5 million aggregate principal amount. Key terms such as …
Morgan Stanley analysts say demand for AI computing capacity should continue to exceed available supply as large language model capabilities advance rapidly and the economic case for AI adoption strengthens. The firm identifies value accruing to holders of key infrastructure bottlenecks - labor, power, and premium hardware - while flagging rising o…
MiNK Therapeutics stock climbed sharply after the company announced a collaboration with the C-Further pediatric oncology consortium to develop a PRAME-targeted T cell receptor-engineered invariant natural killer T cell therapy. The agreement supplies about $1.1 million in non-dilutive support for IND-enabling work and includes milestone-linked pay…
